The table below shows PRECISION BIOSCIENCES INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$11.94M
-$19.05M
-$18.98M
-$31.46M
-$28.87M
$68.07M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-$114.00K
-$314.00K
-$26.00K
-$721.00K
-$818.00K
-$1.13M
Dividends paid
-
-
-
-
DTIL operating cash flow (10-K history)
PRECISION BIOSCIENCES INC reported operating cash flow of -$65.84M for fiscal year 2025. That is down 12.7% from -$58.45M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$51.72M (FY 2018) to -$65.84M. Figures come from the company's audited annual reports as filed with the SEC.